Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.

Wang Y, Hao Y, Alway SE.

J Cell Sci. 2011 Nov 15;124(Pt 22):3835-47. doi: 10.1242/jcs.086686. Epub 2011 Nov 23.

2.

M-cadherin-inhibited phosphorylation of ß-catenin augments differentiation of mouse myoblasts.

Wang Y, Mohamed JS, Alway SE.

Cell Tissue Res. 2013 Jan;351(1):183-200. doi: 10.1007/s00441-012-1515-4. Epub 2012 Nov 9.

3.

Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.

Ohori K, Miura T, Tanno M, Miki T, Sato T, Ishikawa S, Horio Y, Shimamoto K.

Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2079-86. doi: 10.1152/ajpheart.00092.2008. Epub 2008 Sep 19.

4.

Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.

van der Velden JL, Schols AM, Willems J, Kelders MC, Langen RC.

J Biol Chem. 2008 Jan 4;283(1):358-66. Epub 2007 Oct 31.

5.

Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.

Liang Y, Jing Z, Deng H, Li Z, Zhuang Z, Wang S, Wang Y.

Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):70-5. doi: 10.1016/j.bbrc.2015.05.020. Epub 2015 May 15.

PMID:
25986738
6.

TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.

Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH.

Mol Cancer Res. 2012 Aug;10(8):1109-19. doi: 10.1158/1541-7786.MCR-12-0160. Epub 2012 Jun 15.

7.

Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway.

Ye Z, Xia P, Cheng ZG, Guo Q.

J Neurol Sci. 2015 Jan 15;348(1-2):216-25. doi: 10.1016/j.jns.2014.12.011. Epub 2014 Dec 18.

PMID:
25555490
8.

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

Tan J, Geng L, Yazlovitskaya EM, Hallahan DE.

Cancer Res. 2006 Feb 15;66(4):2320-7.

9.

Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.

van der Velden JL, Langen RC, Kelders MC, Willems J, Wouters EF, Janssen-Heininger YM, Schols AM.

Am J Physiol Cell Physiol. 2007 May;292(5):C1636-44. Epub 2006 Dec 13.

10.

Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced suppression of myogenic differentiation in vitro.

Ma Z, Zhong Z, Zheng Z, Shi XM, Zhang W.

PLoS One. 2014 Aug 15;9(8):e105528. doi: 10.1371/journal.pone.0105528. eCollection 2014.

11.

Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.

Nair VD, Olanow CW.

J Biol Chem. 2008 May 30;283(22):15469-78. doi: 10.1074/jbc.M707238200. Epub 2008 Apr 3.

12.

N-Cadherin-Mediated Activation of PI3K/Akt-GSK-3β Signaling Attenuates Nucleus Pulposus Cell Apoptosis Under High-Magnitude Compression.

Li P, Liang Z, Hou G, Song L, Zhang R, Gan Y, Zhang C, Xu Y, Zhou Q.

Cell Physiol Biochem. 2017;44(1):229-239. doi: 10.1159/000484649. Epub 2017 Nov 9.

13.

GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.

Lin CF, Chen CL, Chiang CW, Jan MS, Huang WC, Lin YS.

J Cell Sci. 2007 Aug 15;120(Pt 16):2935-43. Epub 2007 Jul 31.

14.

FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.

Litwiniuk A, Pijet B, Pijet-Kucicka M, Gajewska M, Pająk B, Orzechowski A.

PLoS One. 2016 Jan 19;11(1):e0146726. doi: 10.1371/journal.pone.0146726. eCollection 2016.

15.

LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3beta-inactivation mechanism.

Zhang L, Zhang Y, Xing D.

J Cell Physiol. 2010 Jul;224(1):218-28. doi: 10.1002/jcp.22123.

PMID:
20333643
16.

Role of TLR4-Mediated PI3K/AKT/GSK-3β Signaling Pathway in Apoptosis of Rat Hepatocytes.

Zhang X, Jiang D, Jiang W, Zhao M, Gan J.

Biomed Res Int. 2015;2015:631326. doi: 10.1155/2015/631326. Epub 2015 Dec 7.

17.

Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.

van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM.

Am J Physiol Cell Physiol. 2006 Feb;290(2):C453-62. Epub 2005 Sep 14.

18.

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.

Hepatology. 2002 Dec;36(6):1528-36.

PMID:
12447879
19.

Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J.

J Biol Chem. 2011 May 27;286(21):18414-25. doi: 10.1074/jbc.M110.209718. Epub 2011 Apr 1.

20.

Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.

Lee YJ, Han HJ.

Am J Physiol Renal Physiol. 2010 May;298(5):F1263-75. doi: 10.1152/ajprenal.00475.2009. Epub 2009 Dec 16.

Supplemental Content

Support Center